Standout Papers

MONARCH 3: Abemaciclib As Initial Therap... 2005 2026 2012 2019 1.1k
  1. MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer (2017)
    Matthew P. Goetz, Masakazu Toi et al. Journal of Clinical Oncology
  2. Pharmacogenetics of Tamoxifen Biotransformation Is Associated With Clinical Outcomes of Efficacy and Hot Flashes (2005)
    Matthew P. Goetz, James M. Rae et al. Journal of Clinical Oncology
  3. MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancer (2019)
    Stephen Johnston, Miguel Martín et al. npj Breast Cancer
  4. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and Tamoxifen Therapy (2018)
    Matthew P. Goetz, Katrin Sangkuhl et al. Clinical Pharmacology & Therapeutics
  5. Advances in systemic therapies for triple negative breast cancer (2023)
    Roberto A. Leon‐Ferre, Matthew P. Goetz BMJ

Immediate Impact

1 by Nobel laureates 18 from Science/Nature 56 standout
Sub-graph 1 of 20

Citing Papers

The B7:CD28 family and friends: Unraveling coinhibitory interactions
2024 Standout
Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer
2024 Standout

Works of Matthew P. Goetz being referenced

Regulation of sister chromatid cohesion by nuclear PD-L1
2020
MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancer
2019 Standout

Author Peers

Author Last Decade Papers Cites
Matthew P. Goetz 5378 3339 2997 288 10.6k
Sjoerd Rodenhuis 5971 4238 3355 253 12.7k
Shinzaburo Noguchi 5973 2708 5075 383 13.4k
Gini F. Fleming 7997 2607 3646 326 16.2k
G. Milano 7643 3057 1514 390 12.0k
Daniel W. Visscher 4673 1587 4190 227 10.8k
Paul E. Goss 5306 2016 3746 211 10.3k
William D. Figg 3038 3722 2369 233 10.1k
Lambert Skoog 4227 1536 3457 268 10.1k
Sabine C. Linn 4583 2321 3348 229 8.8k
Jungsil Ro 7720 5123 3610 190 13.1k

All Works

Loading papers...

Rankless by CCL
2026